Immunomedics Stock Price (NASDAQ:IMMU)

Add to My Stocks
$17.01 $0.64 (3.91%) IMMU stock closing price Feb 23, 2018 (Closing)
Prev Close* : $16.37
Market Cap:
$2.82B
Day Low: $16.24
52 Week Low: $4.73
Open: $16.47
Volume: -
Day High: $17.25
52 Week High: $18.93
Dividend:
0.00

Latest Stock Market News

Latest Articles

Immunomedics News - From Partners

IMMU Stockcharts

View IMMU PE ratio, PS ratio stocks charts and compare with peers.
IMMU Chart
Note: Compare Immunomedics stock price history with the index and industry peers.

Immunomedics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
808.58
PB ratio (
price to book ratio
)
-41.39

Immunomedics Returns

ROE
(return on equity)
-

Immunomedics Financial Ratios

Asset Turnover
0.02
Receivables Turnover
6.74
Debt to Equity
1.2
Dividend Yield
0%

IMMU Industry Peers

Company Price Change (%)
China Biologic Products (CBPO)85.181.46 (1.74%)
Argenx Se-adr (ARGX)80.50.77 (0.95%)
Pfizer (PFE)36.260.52 (1.45%)
Eli Lilly (LLY)78.751.56 (2.02%)
Seattle Genetics (SGEN)55.351.57 (2.92%)
Amgen (AMGN)186.674.22 (2.31%)
Alseres Pharma (ALSE)400 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Vital Therapies (VTL)5.30.6 (12.77%)
Fate Therapeutics (FATE)11.761.18 (11.15%)
Sorrento Therapeutics (SRNE)9.10.7 (8.33%)
GTx (GTXI)16.591.1 (7.1%)
Retrophin (RTRX)23.851.51 (6.76%)
Insmed (INSM)25.871.46 (5.98%)
Vanda Pharmaceuticals (VNDA)18.71.05 (5.95%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 24, 2018
CompanyPriceChange (%)
MiMedx (MDXG)7.831.05 (11.82%)
Anika Therapeutics (ANIK)51.696.02 (10.43%)
Lexicon Pharma (LXRX)8.270.58 (6.55%)
EXACT Sciences (EXAS)42.372.62 (5.82%)
Clovis Oncology (CLVS)56.843.04 (5.08%)
NeoGenomics (NEO)8.030.22 (2.67%)
Novavax (NVAX)2.330.06 (2.51%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 24, 2018

Immunomedics, Inc. Stock News - Partner Headlines

Immunomedics Financial Statements

income statement20172016201520142013
Net Sales or Revenues3.09M3.23M5.65M9.04M4.96M
Net Income-153.2M-59.03M-48M-35.42M-12.16M
Total Operating Expense81.75M61.07M51.6M43.09M36.14M
View Immunomedics income statement
balance sheet20172016201520142013
Total Assets162.57M56.95M105.77M46.84M47.92M
Total Liabilities222.03M114.47M110.3M7.98M11.34M
Shareholders Equity-59.46M-57.52M-4.52M38.85M36.58M
View Immunomedics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities15.85M4.85M4.73M3.46M3.38M
Net Cash from (used by) Operating Activities-62.25M-48.46M-38.99M-30.91M-5.89M
Increase (Decrease) in Prop Plant And Equipment-1.83M-2.22M-0.92M-0.37M-0.59M
View Immunomedics cash flow statement

Immunomedics Stock Message Board

An investor needs to spend $17.01 to buy IMMU stock, as the closing Immunomedics stock price is $17.01. Immunomedics market capitalization is $2.82B and it represents the total market value of IMMU stock. Immunomedics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Immunomedics stock price and Immunomedics share price mean the same thing. The volume of shares traded stood at 2,483,422 on the last trading day, as is evident from Immunomedics stock chart, and IMMU stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Immunomedics dividend per share was 0.00 during the last quarter. Immunomedics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.